Relationship Between Renal Dysfunction and Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Pharyngeal Cancer: A Retrospective Cohort Study

Hirofumi Mizuno, Hisataka Miyai, Aya Yokoi, Terumasa Kobayashi, Chiaki Inabu, Takayuki Maruyama, Daisuke Ekuni, Nobuyoshi Mizukawa, Shin Kariya, Kazunori Nishizaki, Yoshihiro Kimata, Manabu Morita

Research output: Contribution to journalArticle

Abstract

BACKGROUND/AIM: The aim of this retrospective cohort study was to investigate the association between renal dysfunction (RD) and the development of oral mucositis (OM) in patients undergoing concurrent chemoradiotherapy (CCRT) for pharyngeal cancer including radiation to the oral cavity. PATIENTS AND METHODS: Of 130 patients diagnosed as having pharyngeal cancer who received CCRT at the Okayama University Hospital Head and Neck Cancer Center, 44 were finally selected. RESULTS: During the observation period, 24 (54.5%) patients experienced severe OM (grade 3). The Cox proportional hazards regression model demonstrated that RD (hazard ratio(HR)=2.45, 95% confidence interval(CI)=1.067-6.116, p=0.035) and nasopharynx/oropharynx as center of the irradiated area (HR=2.56, 95% CI=1.072-5.604, p=0.034) were significantly associated with the incidence of severe OM (grade 3). CONCLUSION: In patients with pharyngeal cancer treated with CCRT including radiation to the oral cavity, RD at baseline can be a risk factor for developing severe OM.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalIn vivo (Athens, Greece)
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Chemoradiotherapy
Pharyngeal Neoplasms
Stomatitis
Hazards
Cohort Studies
Retrospective Studies
Kidney
Mouth
Radiation
Confidence Intervals
Oropharynx
Nasopharynx
Head and Neck Neoplasms
Proportional Hazards Models
Observation
Incidence

Keywords

  • concurrent chemoradiotherapy
  • creatinine clearance
  • Head and neck cancer
  • oral mucositis
  • renal dysfunction

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

@article{e9b3dcefa89e4e9598f83847d6cb76bf,
title = "Relationship Between Renal Dysfunction and Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Pharyngeal Cancer: A Retrospective Cohort Study",
abstract = "BACKGROUND/AIM: The aim of this retrospective cohort study was to investigate the association between renal dysfunction (RD) and the development of oral mucositis (OM) in patients undergoing concurrent chemoradiotherapy (CCRT) for pharyngeal cancer including radiation to the oral cavity. PATIENTS AND METHODS: Of 130 patients diagnosed as having pharyngeal cancer who received CCRT at the Okayama University Hospital Head and Neck Cancer Center, 44 were finally selected. RESULTS: During the observation period, 24 (54.5{\%}) patients experienced severe OM (grade 3). The Cox proportional hazards regression model demonstrated that RD (hazard ratio(HR)=2.45, 95{\%} confidence interval(CI)=1.067-6.116, p=0.035) and nasopharynx/oropharynx as center of the irradiated area (HR=2.56, 95{\%} CI=1.072-5.604, p=0.034) were significantly associated with the incidence of severe OM (grade 3). CONCLUSION: In patients with pharyngeal cancer treated with CCRT including radiation to the oral cavity, RD at baseline can be a risk factor for developing severe OM.",
keywords = "concurrent chemoradiotherapy, creatinine clearance, Head and neck cancer, oral mucositis, renal dysfunction",
author = "Hirofumi Mizuno and Hisataka Miyai and Aya Yokoi and Terumasa Kobayashi and Chiaki Inabu and Takayuki Maruyama and Daisuke Ekuni and Nobuyoshi Mizukawa and Shin Kariya and Kazunori Nishizaki and Yoshihiro Kimata and Manabu Morita",
year = "2019",
month = "1",
day = "1",
doi = "10.21873/invivo.11457",
language = "English",
volume = "33",
pages = "183--189",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Relationship Between Renal Dysfunction and Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Pharyngeal Cancer

T2 - A Retrospective Cohort Study

AU - Mizuno, Hirofumi

AU - Miyai, Hisataka

AU - Yokoi, Aya

AU - Kobayashi, Terumasa

AU - Inabu, Chiaki

AU - Maruyama, Takayuki

AU - Ekuni, Daisuke

AU - Mizukawa, Nobuyoshi

AU - Kariya, Shin

AU - Nishizaki, Kazunori

AU - Kimata, Yoshihiro

AU - Morita, Manabu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND/AIM: The aim of this retrospective cohort study was to investigate the association between renal dysfunction (RD) and the development of oral mucositis (OM) in patients undergoing concurrent chemoradiotherapy (CCRT) for pharyngeal cancer including radiation to the oral cavity. PATIENTS AND METHODS: Of 130 patients diagnosed as having pharyngeal cancer who received CCRT at the Okayama University Hospital Head and Neck Cancer Center, 44 were finally selected. RESULTS: During the observation period, 24 (54.5%) patients experienced severe OM (grade 3). The Cox proportional hazards regression model demonstrated that RD (hazard ratio(HR)=2.45, 95% confidence interval(CI)=1.067-6.116, p=0.035) and nasopharynx/oropharynx as center of the irradiated area (HR=2.56, 95% CI=1.072-5.604, p=0.034) were significantly associated with the incidence of severe OM (grade 3). CONCLUSION: In patients with pharyngeal cancer treated with CCRT including radiation to the oral cavity, RD at baseline can be a risk factor for developing severe OM.

AB - BACKGROUND/AIM: The aim of this retrospective cohort study was to investigate the association between renal dysfunction (RD) and the development of oral mucositis (OM) in patients undergoing concurrent chemoradiotherapy (CCRT) for pharyngeal cancer including radiation to the oral cavity. PATIENTS AND METHODS: Of 130 patients diagnosed as having pharyngeal cancer who received CCRT at the Okayama University Hospital Head and Neck Cancer Center, 44 were finally selected. RESULTS: During the observation period, 24 (54.5%) patients experienced severe OM (grade 3). The Cox proportional hazards regression model demonstrated that RD (hazard ratio(HR)=2.45, 95% confidence interval(CI)=1.067-6.116, p=0.035) and nasopharynx/oropharynx as center of the irradiated area (HR=2.56, 95% CI=1.072-5.604, p=0.034) were significantly associated with the incidence of severe OM (grade 3). CONCLUSION: In patients with pharyngeal cancer treated with CCRT including radiation to the oral cavity, RD at baseline can be a risk factor for developing severe OM.

KW - concurrent chemoradiotherapy

KW - creatinine clearance

KW - Head and neck cancer

KW - oral mucositis

KW - renal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85059240176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059240176&partnerID=8YFLogxK

U2 - 10.21873/invivo.11457

DO - 10.21873/invivo.11457

M3 - Article

C2 - 30587621

AN - SCOPUS:85059240176

VL - 33

SP - 183

EP - 189

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -